川崎病40年治疗与结局:意大利单中心纵向队列研究
该研究纳入1982至2025年意大利单中心533例川崎病患儿,随访急性期特征、治疗及长期冠状动脉结局。22.0%出现急性冠状动脉受累,持续性冠状动脉异常仅见于中型-巨大动脉瘤患者;年龄小于6月、IVIG抵抗、第10天后使用IVIG及心包积液为动脉瘤独立预测因素。
要点
- 22.0%患儿出现急性冠状动脉受累,包括27例动脉瘤和90例扩张。
- 持续性冠状动脉异常仅见于中型-巨大动脉瘤患者。
- 动脉瘤独立预测因素:年龄小于6月、IVIG抵抗、第10天后IVIG、心包积液。
核心结论
- 在该40年意大利队列中,冠状动脉瘤不常见但唯一决定长期冠状动脉后遗症。
- 年龄小、延迟治疗或IVIG抵抗及心包积液独立预测动脉瘤形成,提示诊疗流程存在可改善缺口。
研究设计与样本
- 纵向观察性队列研究,纳入1982至2025年意大利单中心连续诊断为川崎病的儿童。
- 共533例患儿,中位年龄26个月,59.8%为男性;急性期行临床和超声心动图评估,随后每年纵向随访。
主要发现
- 117例(22.0%)出现急性冠状动脉受累,包括27例动脉瘤和90例扩张。
- IVIG使用率从1980年代的53.3%升至2020年后的99%。
- IVIG抵抗率(30.0%)和冠状动脉病变率(27.2%)在2011至2020年间最高,2021至2025年下降。
- 持续性冠状动脉异常仅见于中型-巨大动脉瘤患者。
- 动脉瘤独立预测因素包括年龄小于6月(OR 7.64)、IVIG抵抗(OR 9.89)、第10天后使用IVIG(OR 5.27)和心包积液(OR 3.16)。
关键数值与推荐
- 急性冠状动脉受累定义为超声心动图评估的扩张或动脉瘤。
- 接受白细胞介素-1抑制剂治疗的高危患者未观察到持续性冠状动脉后遗症。
临床怎么用
- 对年龄小于6月、心包积液、IVIG抵抗或延迟使用IVIG的高危患儿应加强冠状动脉监测。
- 支持专科、基于风险的管理,及时升级治疗以减少长期冠状动脉病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed countries. Long-term prognosis depends on coronary sequelae, yet Western longitudinal data integrating acute-phase features, treatment, and long-term coronary outcomes remain limited. METHODS: We conducted a longitudinal observational cohort study including consecutive children diagnosed with KD between 1982 and 2025 at a single tertiary pediatric referral center in Italy. All patients underwent clinical and echocardiographic assessment during the acute phase, followed by longitudinal annual follow-up. Coronary involvement (dilation or aneurysm) was assessed by echocardiography. RESULTS: Among 533 children (median age, 26 months; 59.8% male), 117 (22.0%) developed acute coronary involvement, including 27 aneurysms and 90 dilation. Intravenous immunoglobulin (IVIG) use increased from 53.3% in the 1980s to 99% after 2020. The highest rates of IVIG resistance (30.0%) and coronary lesions (27.2%) occurred between 2011 and 2020, followed by a decline in 2021-2025. Persistent coronary abnormalities were observed exclusively in patients with medium-giant aneurysms. Independent predictors of aneurysm were age less than 6 months (odds ratio [OR], 7.64), IVIG resistance (OR, 9.89), IVIG administration after day 10 (OR, 5.27), and pericardial effusion (OR, 3.16). No persistent coronary sequelae were observed in high-risk patients treated with interleukin-1 inhibitors. CONCLUSIONS: In this 40-year Italian cohort, coronary aneurysms were uncommon but exclusively determined long-term coronary sequelae. Younger age, delayed treatment or IVIG resistance, and pericardial effusion independently predicted aneurysm formation, highlighting major and potentially modifiable gaps in care delivery. These findings support specialist, risk-based management with prompt escalation to reduce long-term coronary morbidity.
引用
- Bonanni F, Claudi G, Vanacore C, et al. Treatment and Outcomes of Kawasaki Disease Over 40 Years. Pediatrics. 2026. PMID: 42722374. doi:10.1542/peds.2026-076338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。